Press Release: PatientCraft Publishes Results of 340B Stakeholders Survey

Survey indicates that understanding 340B software configurations and lack of adequate resources are biggest concerns for 340B program participants

EL PASO – March 14, 2017 – PatientCraft today announced the results from a survey of stakeholders in the 340B Drug Pricing Program conducted at the 13th Annual 340B Coalition Winter Conference in San Francisco from February 1 – 3.

The 340B program provides discounts on pharmaceuticals to hospitals and health centers with underserved and underinsured patient populations. Participating hospitals and health centers, known as covered entities, are required to put in place certain measures to ensure that the patient, prescriber and drug comply with program requirements and to avoid duplicate discounts, where both a 340B discount and Medicaid rebate are applied to the same drug.

Read more